EGFR and glioblastoma: Amplification of the epidermal growth factor receptor locus (EGFR) occurs in ∼40% of GBM, and is considered to be the defining genetic lesion of so‐called primary GBM (GBM that arises de novo rather than evolving from a lower grade astrocytic lesion) 10, 53, 90.